Table 1.
Study Population
| Study Set | Study No. | Study Type | HBsAg | Anti-HBc | Clinical Implication | Group | Follow-up HBV-HCC Status | Follow-up HBV-Liver Cirrhosis Status |
|---|---|---|---|---|---|---|---|---|
| Taiwan Biobank | 6187 | Biobank | Negative | Positive | Past infection | Healthy individuals who cleared HBV | NA | NA |
| REVEAL-HBV | 3416 | Longitudinal cohort | Positive | Positive | Chronic hepatitis B infection | Chronic hepatitis B carriers | Incident HCC (n = 306) | Incident liver cirrhosis (n = 339) |
| Taiwan Liver Cancer Network | 400 | Biobank | Positive | Positive | Chronic hepatitis B infection | Chronic hepatitis B carriers (HCC) | NA | NA |
Abbreviations: HBc, hepatitis B core; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; NA, not applicable.